Full text is available at the source.
Phytomedicine : international journal of phytotherapy and phytopharmacology···
How a Modified Herbal Treatment May Improve Type 2 Diabetes by Changing Gut Bacteria, Bile Acids, and TGR5 Receptor
Updated
Abstract
Modified Gegen Qinlian Decoction significantly reduced blood glucose levels in T2DM mice over a 12-week treatment period.
- Improvement in oral glucose tolerance and blood lipid levels was observed in the treated mice.
- The modified GQD alleviated damage to the ileum and pancreas associated with T2DM.
- Regulation of intestinal flora and enhancement of bile acid metabolism were noted as key effects.
- Activation of the TGR5/cAMP/PKA/CREB signaling pathway was associated with increased GLP-1 secretion.
Simplified
BACKGROUND: Currently, there are many drugs available for the treatment of type 2 diabetes mellitus (T2DM), but most of them cause various side effects due to the need for long-term use. As a traditional Chinese medicine, Gegen Qinlian Decoction (GQD) has shown good efficacy and low side effects in the treatment of T2DM in both clinical and basic research. Based on relevant traditional Chinese medicine theories, dried ginger is innovatively added the formula of traditional GQD to create a modified GQD. This modification reduces the side effects of traditional GQD while exerting its therapeutic effect on T2DM. Previous studies have found that the modified GQD can regulate endoplasmic reticulum stress in the liver, inhibit hepatic gluconeogenesis, protect pancreatic islet β cells, and control blood sugar levels by inhibiting the FXR/neuronal ceramide signaling pathway. GQD can also regulate the intestinal microbiota to achieve therapeutic and protective effects in various gastrointestinal diseases. However, there is no research exploring whether the modified GQD achieves its therapeutic mechanism for T2DM by regulating the intestinal microbiota.
PURPOSE: To explore the mechanism of modified GQD in the treatment of T2DM based on multi-omics, focusing on its effect on the "intestinal flora bile acid TGR5'' axis.
METHODS: The T2DM model was established using db/db mice, which were randomly divided into a model group, metformin group, high-dose GQD group, medium-dose GQD group, low-dose GQD group, while m/m mice were used as blank control. The drug intervention lasted for 12 weeks, during which the general conditions, oral glucose tolerance (OGT), blood glucose, and lipid-related indexes were recorded. Additionally, the fasting insulin (FINS), c-peptide, GLP-1 in serum, and cAMP in the ileum were measured by ELISA assay. Furthermore, the composition, abundance, and function of the intestinal microbiota were determined by macro genome sequencing, while bile acid was detected by targeted metabonomics. For histological evaluation, HE staining was used to observe the pathological changes of the ileum and pancreas, and the ultrastructure of the ileum and pancreas was observed by transmission electron microscopy. Apoptosis in the ileum tissue was detected by Tunel staining. Moreover, the mRNA and protein expressions of TGR5, PKA, CREB, PC1/3, GLP-1, and their phosphorylation levels in the ileum were detected by qPCR, immunohistochemistry, and Western blot; The expression of INS in the pancreas was also evaluated using immunohistochemistry. Finally, double immunofluorescence staining was used to detect the co-localization expression of TGR5 and GLP-1, NeuroD1, and GLP-1 in the ileum.
RESULTS: The modified GQD was found to significantly reduce blood glucose, improve oral glucose tolerance, and blood lipid levels, as well as alleviate the injury of the ileum and pancreas in T2DM mice. Furthermore, modified GQD was found to effectively regulate intestinal flora, improve bile acid metabolism, activate the TRG5/cAMP/PKA/CREB signal pathway, and stimulate GLP-1 secretion.
CONCLUSION: GQD can regulate the "intestinal flora-bile acid-TGR5" axis and has a therapeutic effect on T2DM in mice.
Related papers
Aug '21
Gegen Qinlian Decoction’s effects on liver sugar production in diabetic rats through a pathway controlling cell energy use and stress
cited by 12 papers
journal article
Nov '21
How gut inflammation and microRNA in cell particles relate to type 2 diabetes and the treatment effects of Gegen Qinlian Decoction
top 20% journal
cited by 10 papers
journal article
Oct '23
How Puerariae Lobatae Root May Reduce Insulin Resistance in Type 2 Diabetic Mice by Changing Gut Bacteria
cited by 2 papers
english abstract
Jul '20
How Gegen Qinlian Decoction may work to treat type 2 diabetes using network analysis and drug testing
top 20% journal
cited by 35 papers
journal article
Nov '22
Gegen Qinlian decoction may help heal the gut lining in ulcerative colitis mice by changing gut bacteria and tryptophan metabolism through the AhR/IL-22 pathway
top 20% journal
cited by 73 papers
journal article
Oct '21
GQD, a Traditional Chinese Medicine, may improve diabetes in rats by changing gut bacteria
top 10% journal
cited by 30 papers
research support, non-u.s. gov't
Apr '24
Shouhuitongbian's blood sugar-lowering effects linked to changes in gut bacteria
top 10% journal
cited by 19 papers
journal article
Jul '21
GeGen QinLian decoction may ease flu-related pneumonia by changing gut bacteria
top 10% journal
cited by 51 papers
journal article
Mar '23
Jiang-Tang-San-Huang pill may improve type 2 diabetes by changing gut bacteria and bile acid processing
top 10% journal
cited by 65 papers
journal article
Jan '16
Activation of a bile acid sensor in pancreas cells helps regulate blood sugar
top 10% journal
cited by 126 papers
research support, n.i.h., extramural